FUS and esophageal squamous cell carcinoma: Likewise, Zhang et al. [36] demonstrated that GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis, which aligns with our research findings.